Essay
Published an essay distinguishing competitive moats from underlying asset value in startup investing.
The moat decides whether you can play. The asset decides whether you get paid
AUG 11, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
The moat decides whether you can play. The asset decides whether you get paid
Olio Labs
Cirrus Therapeutics
FinalDose
ParcelBio
Sygaldry
DeepSeq.AI
Ateios Systems
Elucidate Bio
Cirrus Therapeutics
Mews
Flexkeeping
Flexkeeping
Filip Orth leads Silicon Valley office